Healthcare -
Biotechnology - NASDAQ - US
$ 1.875
-3.85 %
$ 393 M
Market Cap
-1.21
P/E
ALLO - ACCOUNTS PAYABLE
Accounts Payable ALLO - Allogene Therapeutics, Inc.
5.9 M
LAST VALUE
-24.17%
2 YEAR CAGR
-13.73%
5 YEAR CAGR
0.00%
10 YEAR CAGR